Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 13668-760

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 13668-760). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ranolazine Extended-release Tablets 1000 mg (NDC 13668-760-60)

Each extended-release tablet contains Ranolazine 1,000 mg. The dosage information can be found in the package insert. Store the tablets at 25°C with excursions permitted between 15° to 30°C. The tablets should be swallowed whole and not crushed, broken, or chewed. The label size is 140 mm x 50 mm. The tablets are manufactured by VKT Pharma Private Limited in Srikakulam, India.*

FDA Label Image

Ranolazine Extended-release Tablets 500 mg (NDC 13668-759-60)

FDA Label Image

Structure (Ranolazine Ext Rel Tabs Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.